Publication | Open Access

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

UrologyMetastatic Urothelial CarcinomaGenitourinary CancerMedicineCancer TreatmentOncologyRadiation OncologyMolecular OncologyAtezolizumab Versus Chemotherapy